Pair Name | Magnoflorine, Doxorubicin | ||
Phytochemical Name | Magnoflorine (PubChem CID: 73337 ) | ||
Anticancer drug Name | Doxorubicin (PubChem CID: 31703 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Doxorubicin |
Adverse Reactions | Nausea, vomiting, diarrhoea. This was inferred cold nature anticancer drug. |
Recommendations | Hot: Ligusticum chuam; Angelica sinensis; Zingiber officinale; Panax ginseng; Pogostemon cablin |
Reference | ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899. ref_link |
Pair Name | Magnoflorine, Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | BECN1 | hsa8678 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Up-regulation | Expression | CDKN1A | hsa1026 | |
Up-regulation | Expression | MAP1LC3B | hsa81631 | |
Up-regulation | Phosphorylation | MAPK14 | hsa1432 | |
Down-regulation | Phosphorylation | MTOR | hsa2475 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
Down-regulation | Expression | SQSTM1 | hsa8878 | |
Up-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
In Vivo Model | 1×10⁷ MCF-7 cells suspended in 0.2 ml PBS were injected into the right flank of each mouse at a single site. | |||
Result | Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways |
No. | Title | Href |
---|---|---|
1 | Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. Biomed Pharmacother. 2020 Jan;121:109139. doi: 10.1016/j.biopha.2019.109139. | Click |